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Abstract: 34 
 35 
STUDY QUESTION: Does age of the sperm donor have an effect on reproductive outcomes 36 
(live birth and miscarriage occurrence) of Donor Insemination or In-Vitro Fertilization 37 
treatment using donated sperms? 38 
SUMMARY ANSWER: Live birth and miscarriage occurrence in assisted reproduction 39 
treatment using donor sperms was not found to be affected by the sperm donor age 40 
(recorded up to 45 years of age).  41 
WHAT IS ALREADY KNOWN: Literature on the effect of sperm donor age on outcome of 42 
medically assisted reproduction (MAR) is scarce. Most researchers agree that semen 43 
parameters deteriorate with increasing paternal age. However, there is no substantial 44 
evidence to suggest that this deterioration adversely affects the reproductive outcomes in 45 
couples undergoing Medically Assisted Reproduction. 46 
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STUDY DESIGN, SIZE, DURATION: A retrospective cohort study analysing 46,078 first fresh In-47 
vitro fertilization (IVF)/Intracytoplasmic sperm injection (ICSI) and Donor insemination (DI)  48 
treatment cycles using donated sperms from 1991 to 2012. 49 
PARTICIPANTS/ DURATION/METHODS: The first fresh IVF/ICSI and DI treatment cycles 50 
(46,078 treatment cycles) using donated sperms from the UK’s regulator, HFEA’s long term 51 
anonymised data registry from 1991 to 2012 were analysed by the binary logistic modelling 52 
technique for association between sperm donor age and reproductive outcomes (live birth 53 
occurrence and miscarriage occurrence) .The statistical package SPSS (version 21) was used 54 
for analysis and results were considered to be statistically significant if the p value was 55 
<0.05. 56 
MAIN RESULTS AND THE ROLE OF CHANCE: In our study, no evidence of declining likelihood 57 
of live birth with increasing sperm donor age was found. Results were not suggestive of any 58 
unfavourable effect of advancing sperm donor age on the odds of miscarriage occurrence.  59 
 LIMITATIONS, REASONS FOR CAUTION: As sperm donors are a select population based on 60 
good semen indices, the generalization of results to the paternal population at large may 61 
not be possible. Although study sub-groups were controlled for female age, treatment 62 
modality and effect of previous treatment cycles, adjustments for certain potential 63 
compounding factors like smoking status, BMI of women and stimulation protocol used for 64 
stimulation in IVF/ICSI treatment cycles were not possible. 65 
WIDER IMPLICATIONS OF THE FINDINGS: Live birth and miscarriage occurrence following 66 
assisted reproduction weren’t adversely affected by increasing sperm donor age up to 45 67 
years. In view of the increasing demand for donor sperms, further studies may be required 68 
to ascertain the safe upper age limit for sperm donors. 69 
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STUDY FUNDING/COMPETING INTEREST(S): No funding was received from any individual or 70 
funding agency. NG was on a Commonwealth Scholarship for the duration of conducting the 71 
study. Authors do not have any conflicts of interest to declare. 72 
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 75 
Introduction: 76 
Infertility affects one in every seven couples in UK and in approximately 25% of these 77 
couples is due to factors in the male (National Institute of Clinical Excellence, 2013). 78 
Donated sperms may represent the only hope for some of these infertile couples to 79 
conceive. With ever-emerging societal changes in lifestyle and personal choices, single 80 
women and same sex female couples are also tapping into the resource of donor sperm to 81 
form a family.  In the UK, 2013 saw a 30% rise of same sex female couples receiving 82 
treatment using donated sperm compared to 2012 (Human Fertilisation and Embryology 83 
Authority (HFEA), 2014). This increased demand for donated sperms has led to a steady 84 
increase in the number of imports of sperm from overseas sperm banks over the years. 85 
Overseas sperm donors constituted almost a third of newly registered sperm donors in 2013 86 
(compared to 11% in 2005). 87 
Although, as per current professional guidelines in the UK, men aged 41 years and over 88 
should not be accepted as sperm donors, the Human Fertilisation and Embryology 89 
Authority’s (HFEA) egg and sperm donation statistics report, published in 2014, reveals that 90 
the majority of newly registered sperm donors in 2012-2013 were 26 or older with a quarter 91 
over 40 years of age (HFEA, 2014).  The HFEA long term data registry (1991-2012) reveals 92 
that post anonymity removal (2005-2012), 60% of sperm donors were aged between 31-45 93 
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years whereas this figure was 28% before donor anonymity removal (1991-2004) (HFEA, 94 
2013). In our fertility centre, a similar rising trend in sperm donor age was noted with mean 95 
age (±SD) of 26.6 years (± 7.38) and 34.72 years (± 7.57) pre and post donor anonymity 96 
removal respectively (unpublished data). 97 
 This raises certain issues in the minds of clinicians and couples alike concerning the effect of 98 
sperm donor age on success rates of medically assisted reproduction (MAR) and the upper 99 
age cut-off for these donors. There have been numerous studies (Dunson et al., 2002; 100 
Noord-Zaadstra et al., 1991; Schwartz and Mayaux, 1982; Scott  et al., 1995) in published 101 
literature confirming the negative effect of increasing maternal age on female fertility and 102 
outcome of MAR, but paternal age influence on these outcomes is less well researched and 103 
contentious and still rarer is literature on the effect of sperm donor age on outcome of 104 
medically assisted reproduction.  Reports on the negative impact of increasing paternal age 105 
on fertility outcome and child health (Robertshaw  et al., 2013; de la Rochebrochard  et al., 106 
2003) may cause anxiety for couples who are faced with limited donor choice and rising age 107 
of the sperm donor. The majority of published literature has considered the effect of 108 
paternal age in the general population or in IVF cases with ovum donation. Questions 109 
concerning the effect of sperm donor age on success rates of assisted reproduction 110 
techniques have largely remained unanswered. 111 
 Hence it is vital that we furnish information to couples based on evidence so as to help 112 
them make an informed decision. In the UK, all centers offering donor sperm treatments are 113 
registered with HFEA and the HFEA dataset provides a rich mine of raw anonymised data to 114 
analyse these treatment outcomes. In this study, using the large, anonymised HFEA national 115 
database collected over two decades, we set out to determine the effect of sperm donor 116 
age on the chances of live birth occurrence in women undergoing medically assisted 117 
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reproduction treatment. Our aim was to answer the question: does the age of sperm donor 118 
affect the chances of success in women undergoing medically assisted reproduction? 119 
 120 
Material and Methods: 121 
Study population and participants: 122 
In an attempt to find an answer to the above question we looked at the freely available 123 
HFEA long term anonymised data registry from 1991 to 2012 (HFEA, 2013).  124 
The HFEA pipe delimited dataset was converted to an Excel spreadsheet format and was 125 
imported to MS Excel package 2007. Of the total 1,048,575 treatment cycles, the number of 126 
cycles using donated sperms was 237,852. Figure 1 depicts the breakdown of the number of 127 
the donor sperm treatments analysed following exclusions. Restricting the analysis to first 128 
cycles enabled us to alleviate the compounding effect of previous cycles and to report 129 
results as per individual woman rather than per cycle. To adjust for women’s age, two 130 
groups were selected and separately analysed - women between 18-34 years with optimum 131 
reproductive potential and women > 37 years (i.e. 38-50 years) which is taken as the 132 
conventional cut off for decline of female fertility. An additional analysis was conducted to 133 
determine the influence of women at the farthest end of the age spectrum (45-50 years) 134 
whereby results for women in the 38-50 year and 38-44 year age brackets were compared 135 
(data provided upon request).  As the results were no different, the whole group (38-50 year 136 
old women) was included in the final analysis.  For entirety, women aged 35-37 years were 137 
also studied as a third group. Within these three groups, donor insemination (DI) treatment 138 
cycles and IVF/ICSI treatment cycles were analysed separately. In all the six groups, donor 139 
age categories were compared for live birth occurrence rates and occurrence of miscarriage. 140 
The categories chosen for sperm donor age (≤20, 21-25, 26-30, 31-35, 36-40 and 41-45) 141 
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were similar to those used by the HFEA for data collection. Live birth occurrence (one live 142 
birth occurrence is one birth event in which at least one baby is born alive) rather than 143 
actual numbers of live births was used as the output measure. Likewise miscarriage 144 
occurrence rather than actual number of miscarriages was analysed. HFEA data was also 145 
searched for congenital abnormalities at birth in all the study groups. 146 
Exclusions: 147 
The cycles with missing data for the woman or sperm donor age were excluded from the 148 
analysis. Treatment cycles involving gamete or zygote intra-fallopian transfer (GIFT, ZIFT), 149 
cycles, using egg donation, frozen embryos or surrogacy were excluded from the analysis. 150 
Out of 49,242 women undergoing first sperm donation treatment cycles 46,078 women 151 
were finally included in the live birth analysis (the remaining 3,164 women were excluded 152 
due to reasons explained in Figure 1). For the miscarriage analysis, a further 2,990 153 
treatment cycles were excluded due to unrecorded data on early outcome (Supplementary 154 
data-Figure 1).   155 
Statistical Analyses: 156 
Live birth occurrence was taken as the dependent variable and donor age, in categorical 157 
fashion, was used as a covariate. As the outcome could take one of two qualitative 158 
categories (e.g. live birth occurrence or no live birth occurrence), the binary logistic 159 
modelling technique was employed to establish the strength and pattern of association 160 
between outcome and sperm donor age (Lewis-Beck, 1980). This modelling technique 161 
requires few distributional assumptions and is applicable with either continuous or discrete 162 
explanatory variables, or both. The statistical package SPSS (IBM Corp. Released 2012. IBM 163 
SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.) was used for analysis and 164 
results were considered to be statistically significant if the p value was <0.05.  In an effort to 165 
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improve the transparency of the results, the odds ratio (OR) and 95% CI (confidence 166 
intervals) were also calculated. In this study, the binary logistic model expresses the odds of 167 
live birth occurrence as: 168 
 169 
 1 −  = exp	( +	 +  +⋯) 
p is the probability of a live birth occurrence. 170 
, , …  and θ are unknown parameters that are estimated from the data. 171 
For the categorical covariate, one category acts as the reference category – all other 172 
categories are compared to the reference category.  In this study, donor age 41-45 years 173 
was taken as the reference level. As older sperm donors act as the reference category – the 174 
model enabled us to estimate the effect (on live birth occurrence) of being in a younger age 175 
group rather than the oldest age group. We hypothesise that a younger sperm donor would 176 
have an increased odds of live birth compared to an older donor assuming that increasing 177 
age has a similar effect on male fertility as on female fertility. Therefore, we decided to take 178 
older sperm donors as the reference category. 179 
As the number of embryos transferred in each cycle may be an independent compounding 180 
factor, a one way ANOVA test was used to compare mean embryos transferred and embryos 181 
created per cycle in each donor age category.  This test was conducted in all three female 182 
age subgroups undergoing IVF/ICSI treatment. If the overall ANOVA test proved significant, 183 
it was decided to use the multiple comparisons Dunnett’s test to establish if each of the 184 
younger sperm donor age categories had a higher mean number compared to oldest (41-45 185 
year old) category. 186 
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Similarly the relationship between donor age and the binary response “occurrence of 187 
miscarriage” was investigated. We investigated overall pregnancy loss combining 188 
biochemical pregnancy loss (after positive pregnancy test) and clinical pregnancy loss (after 189 
gestational sac has been demonstrated by ultrasound scan). Ectopic pregnancies, pregnancy 190 
terminations and heterotropic pregnancies were excluded from the analysis. The binary 191 
logistic modelling technique was again used. A wealth of medical literature proves that the 192 
likelihood of miscarriage increases if the woman is aged ≥35 years (Nybo Andersen et al. 193 
2000; Heffner, 2004; Cleary-Goldman et al, 2005). Also there are studies in published 194 
literature (de La Rochebrochard and Thonneau, 2002; Kleinhaus et al., 2006)  which indicate 195 
that increased paternal age is a risk factor for miscarriage therefore, as a corollary, we 196 
hypothesised that an older sperm donor would have an increased odds of miscarriage 197 
compared to a younger donor. Hence, here too the 41-45 years sperm donor age group was 198 
taken as the reference category for analysis.  199 
HFEA data was also consulted for congenital abnormalities at birth in all six study groups. 200 
Ethical Approval: 201 
Formal ethical approval was not indicated as the freely available HFEA anonymised dataset 202 
was used for data procurement. 203 
 204 
Results: 205 
Of 46,078 women, 84.58% (N=38,974) underwent donor insemination (DI) treatment and 206 
the rest 15.42% (N=7,104) had IVF/ICSI treatment with donor sperms. In the donor 207 
insemination group, 66.51% (N=25,925) women were aged 18-34 years, 16.82% (N=6,559) 208 
were aged 35-37 years whilst the remaining 16.65% (N=6,490) were between 38-50 years of 209 
age. Similarly in the IVF/ICSI treatment group, 51.01% (N=3,624) of the women were in the 210 
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18-34 years age category, 19.10% (N=1,359) were aged 35-37 years and 29.85% (N=2,121) 211 
of the women belonged to the 38-50 years age category. The numbers of women in each 212 
sperm donor age category in all six study groups have been tabulated in supplementary 213 
table-1. 214 
Mean embryos transferred per cycle in IVF/ICSI treatment group: 215 
The mean number of embryos transferred per women was 1.86, 1.88 and 1.81 for women 216 
aged 18-34, 35-37 and 38-50 years respectively. Single embryo transfer was recorded in 217 
17.85%, 17.44% and 16.78% women in these age brackets respectively. It was observed that 218 
the mean embryos transferred per cycle were higher in younger sperm donor categories 219 
than in the 41-45 years sperm donors (Supplementary Table 2). To assess whether number 220 
of embryos transferred were linked to number of embryos generated, we analysed the 221 
number of embryos created per cycle using a 1-way ANOVA. For all three women’s age 222 
subgroups undergoing IVF/ICSI treatment there was no evidence of a difference between 223 
the sperm donor age categories as regards the mean number of embryos created 224 
(Supplementary Table 3).  225 
Association of live birth occurrence and sperm donor age: 226 
The overall live birth occurrence was 9.54% in the DI treatment group and 22.76% in women 227 
undergoing IVF/ICSI treatments. In the DI treatment group, the live birth occurrence was 228 
11.07% in 18-34 year old women, 8.30% in 35-37 year old women and 4.70% in 38-50 year 229 
old women. The corresponding figures in the IVF/ICSI treatment group were 28.89%, 22.00% 230 
and 12.91% respectively. Figures 2 and 3 compare odds of having a live birth occurrence in 231 
the different sperm donor age categories for DI and IVF/ICSI treatment cycles for different 232 
women’s age brackets.  233 
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When applying binary logistic regression modelling, we hypothesised that the odds of 234 
having a live birth would increase as the sperm donor age decreased (compared to the 235 
oldest donor age group) – however this pattern was not apparent. It was also observed that 236 
the difference in odds of live birth between each age category and the oldest donor age 237 
group was generally not statistically significant. Tables 1, 2 show the odds ratio  for  live 238 
birth occurrence among all the donor age categories in the DI and IVF/ICSI treatment groups 239 
respectively taking the odds of having a live birth occurrence in the reference sperm donor 240 
category (41-45 years) as one. By including “number of embryos transferred per cycle” as a 241 
covariate in the binary logistic regression model, we obtained adjusted estimates for the age 242 
categories:  younger sperm donors were observed to have a lower odds ratio of live birth 243 
occurrence when compared to the oldest sperm donor age group and this was generally 244 
statistically significant in 18-34 year old women. The difference, generally, did not show 245 
statistical significance in 38-50 year old women (Supplementary data-Table 4). 246 
 247 
Association of miscarriage occurrence and sperm donor age: 248 
 Overall, 1.50% women miscarried during their first donor insemination treatment cycle. 249 
When adjusted for female age, the miscarriage occurrence (i.e. number of miscarriages per 250 
100 women commencing treatment) was 1.31% in 18-34 year old women, 1.86% in 35-37 251 
year old women and 1.89% in 38-50 year old women undergoing donor insemination 252 
treatment. In the sperm donation IVF/ICSI treatment group, these figures were 6.58% 253 
(overall), 5.74%, 8.44% and 6.83% respectively. Miscarriage rate (i.e. number of miscarriages 254 
per 100 positive pregnancy tests) for 18-34 year old women was 10.55% in the DI group and 255 
8.70% in IVF/ICSI treatment group. Corresponding figures in 35-37 year old women were 256 
15.35% and 14.94% and in older women (38-50 years) were 23.24% and 18.50%. 257 
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The association between miscarriage occurrence and the age of sperm donor was explored 258 
using binary logistic regression. We hypothesised that the odds of having a miscarriage 259 
would be lower in the younger sperm donor age categories (vis-a-vis the oldest donor age 260 
group). For the donor insemination group, no significant difference was observed between 261 
each sperm donor age category and the oldest group as regards odds of miscarriage (Table 262 
3). In the IVF/ICSI treatment group, following adjustment for “number of embryos 263 
transferred”, the odds of miscarriage occurrence, was generally not significantly different for 264 
the various sperm donor age categories when compared to the oldest group (Table 4).   265 
 266 
Association of congenital abnormalities at birth occurrence and sperm donor age: 267 
Upon examination of the HFEA long term data registry, the congenital abnormalities if 268 
mentioned, were recorded in extremely low numbers, hence, a meaningful analysis was not 269 
feasible.  270 
 271 
Discussion: 272 
There is no consensus amongst the key professional bodies about the upper sperm donor 273 
age limit, with HFEA (UK) recommending <41 years  (HFEA code of practice: guidance note 274 
11), ASRM (USA) 40 years (Practice Committee of the American Society for Reproductive 275 
Medicine, and Practice Committee of the Society for Assisted Reproductive Technology., 276 
2013), Human Reproduction Act (Australia), 45 years (Reproductive Technology 277 
Accreditation Committee., 2010) and ESHRE (Europe) recommending <50 years (ESHRE task 278 
force on ethics and law., 2002). This lack of consensus demonstrates the paucity of evidence 279 
to show linkage of increasing male age and reproductive outcomes. In our study, we report 280 
that there is no evidence to showcase any decline in the likelihood of live birth with 281 
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increasing sperm donor age. Adjusting for female age, treatment modality and alleviating 282 
the compounding effect of previous cycles it was found that each donor age category was 283 
not significantly different when compared to the oldest donor age group (up to 45 years of 284 
age) with respect to live birth and miscarriage occurrence. Interestingly, we found a higher 285 
number of embryos transferred per cycle in younger sperm donor categories when 286 
compared to older sperm donor categories (generally statistically significant), even though 287 
the number of embryos created per cycle was comparable in all the donor age categories. 288 
After adjusting for number of embryos transferred per cycle, the odds of live birth 289 
occurrence was in general, lower for younger sperm donors compared to older sperm donor 290 
age category in 18-34 year old women. A conceivable explanation for this observation  291 
(young sperm donors requiring more embryos to be transferred  and lower live births 292 
compared to older sperm donors), may be attributed to the embryo quality or other 293 
unknown compounding factor unrecorded in the HFEA data.  As data on embryo quality was 294 
not recorded in HFEA dataset, further exploration into this subject was not feasible and 295 
hence we refrain from making concrete conclusions on this issue and suggest the need for 296 
further studies.  297 
Most researchers agree that semen parameters especially semen volume (de La 298 
Rochebrochard and Thonneau , 2005; Neme et al., 2007) and often sperm motility (Brian et 299 
al., 2011) deteriorate with increasing paternal age while sperm morphology and 300 
concentration largely remain unaffected (Frattarelli et al., 2008). However published 301 
literature is not in consensus about whether this deterioration in semen parameters 302 
translates into decreased clinical pregnancy rate in couples undergoing MAR (Brian et al., 303 
2011; Duran et al., 2010).  304 
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Though there is paucity of published work evaluating association of sperm donor age and 305 
live birth rate, our study agrees with Paulson and co-workers (Paulson et al., 2001), 306 
Whitcomb and colleagues (Whitcomb et al., 2011) and Begueria and colleagues (Begueria et 307 
al., 2014) who observed no correlation between paternal age and pregnancy outcomes in 308 
ovum donation models. Similar to our study, all the three studies have examined live birth 309 
rate in proportion to all treatment cycles. The results of the present study are also in 310 
consensus with a study by Luna and co-workers (Luna et al., 2009) who observed no 311 
significant decrease in clinical pregnancy rates in couples with paternal age below 60 years 312 
using ovum donation models. Frattarelli and coworkers (Frattarelli et al., 2008) observed a 313 
decrease in live birth rate (among known pregnancies) after 50 years of paternal age in their 314 
study on donor oocyte treatment cycles although this study was not adjusted for recipient 315 
female age. Our study findings were different from the results of a study undertaken by 316 
Robertshaw and colleagues (Robertshaw et al., 2013) which demonstrates 26% lower odds 317 
of live birth rate with each 5-year increase in paternal age from 25 years of age, however 318 
small sample size was their major limitation. Another key feature that we need to take into 319 
account is that the studies listed above look at effect of paternal age and live birth outcome 320 
but do not specifically address the effect of sperm donors’ age as sperm donors are likely to 321 
be a selective population based on their optimum sperm quality. Unpublished data from our 322 
centre shows only 1 in 5 enquiries progress on to become sperm donors. 323 
No evidence of an increase in odds of miscarriage among the older sperm donors was 324 
suggested by our study. In our study we investigated miscarriage occurrence (miscarriages 325 
among all women undergoing treatment) rather than calculating miscarriage rate based on 326 
total number of pregnancies, as this approach is less prone to theoretical risk of over-327 
estimation of miscarriage risk due to  decrease in the probability of a pregnancy by 328 
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increasing age.  Our study findings are in agreement with Begueria and colleagues (Begueria 329 
et al., 2014) who observed no difference in miscarriage occurrence among different male 330 
age groups using an ovum donation model. Ferreira and colleagues (Ferreira et al., 2010) 331 
also observed no influence of paternal age on miscarriage outcome, after making 332 
adjustments for maternal age, in couples undergoing ICSI treatment. However, the majority 333 
of published medical literature examines miscarriage rate in proportion to all known 334 
pregnancies. Our findings are in consensus with Luna and co-workers (Luna et al., 2009) 335 
who, in an ovum donation model, reported no statistically significant correlation between 336 
clinical pregnancy loss and increasing paternal age, whereby estimating pregnancy loss in 337 
proportion to number of clinical pregnancies. Similar results were observed by Andersen 338 
and colleagues in a Danish population based cohort study of spontaneous pregnancies 339 
(Nybo Andersen et al., 2004). The study results differ from work by Rochebrochard and 340 
Thonneau who, in a population based study examining spontaneous conceptions, have 341 
shown 6.73 (95% CI, 3.50–12.95) OR of miscarriage in couples where females were aged ≥35 342 
years and male partners were aged 40-64 years, with couples having partners aged 20-29 343 
years being used as the reference category (Rochebrochard et al., 2002). This study was not 344 
adjusted for the compounding effect of female age on miscarriage rate as couple age 345 
instead of male age was analysed. Likewise Slama et al. have shown a 1.26 times higher risk 346 
of spontaneous miscarriages (6-20 week pregnancy loss) if the paternal age was 35 years or 347 
above as compared to fathers aged less than 35 years (Slama et al., 2005). However, our 348 
findings suggest that a sperm donor aged 41-45 years does not have higher odds of 349 
miscarriage when compared to a younger sperm donor. 350 
Zhu Jin Laing and co-workers (Zhu et al., 2005) in a population based cohort study on 71,937 351 
couples found no association between paternal age and congenital malformations at birth. 352 
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These findings are also supported by other studies (Polednak., 1976 and Kazaura et al., 353 
2004). Any positive relationship of trisomy 21 and advancing paternal age is conflict-ridden 354 
as it is observed by some (Stene et al., 1981) and refuted by others (Carothers et al., 1984; 355 
Martin and Rademaker., 1987; Hook and Regal., 1984). Martin and Rademaker 356 
demonstrated significant higher frequency of hyper haploid sperm complement in younger 357 
men as compared to older men thus indirectly showing negative evidence for a relationship 358 
between paternal age and numerical chromosomal abnormalities (Martin and Rademaker., 359 
1987). Autosomal dominant disorders like anchondroplasia, Apert syndrome, Marfan 360 
syndrome etc. have been observed to be associated with increasing paternal age (Jones et 361 
al., 1975). Published literature has also linked increasing paternal age to neurocognitive 362 
disorders like autism, schizophrenia and bipolar disorders (Wiener-Megnazi et al., 2012). 363 
Plas et al., in a review study has recommended that the sperm donor age should be less 364 
than 50 years in consideration of increased risk of structural chromosomal abnormalities 365 
with advancing paternal age (Plas et al., 2000).In the present study, as very few congenital 366 
abnormalities recorded were in the HFEA data (the number was nil in many subgroups), an 367 
evocative analysis in this regard was not possible. Exploration of association of autosomal 368 
dominant diseases and neurocognitive disorders is beyond the scope of this study. 369 
Alio and co-workers (Alio et al., 2012) have observed increased risk of stillbirth, preterm 370 
births and low birth weights in infants born to fathers greater than 45 years of age and 371 
elevated likelihood of small for gestational age, prematurity and low weight births in those 372 
born to fathers less than 24 years in a population based study. The study does not look into 373 
these outcomes and concentrates on live birth as the key parameter of success of assisted 374 
reproduction and the outcome expected by couples seeking this treatment. Moreover, our 375 
study does not address reproductive outcomes for sperm donors more than 45 years and is 376 
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based on age of selected population of sperm donors rather than paternal age of men 377 
undergoing fertility treatment.   378 
One of the major strengths of this study lies in the fact that it analyses one of the largest 379 
and comprehensive databases available on fertility and medically assisted reproduction 380 
outcomes. This greatly increases the power of the study and its internal validity. In an effort 381 
to reduce confounding variables, different study sub-groups were controlled for female age, 382 
treatment modality and effect of previous treatment cycles. Sub-groups were not adjusted 383 
for potential compounding factors like smoking status, BMI of women and stimulation 384 
protocol used for stimulation in IVF/ICSI treatment cycles as no data was available on these 385 
factors in the anonymised HFEA data registry. However we presume that, given the large 386 
data, any unknown compounding factors (and their confounding effect on results) will be 387 
randomly distributed among groups. Sperm donor age was analyzed in categorical fashion 388 
as the format of HFEA anonymised data precludes exploration of sperm donor age as a 389 
continuous variable. We were unable to analyze sperm donors beyond 45 years of age as 390 
sperm donor age is recorded only up to 45 years in the anonymised data. As sperm donors 391 
are a select population based on good semen indices, the generalization of results to the 392 
paternal population at large may not be possible. In addition, HFEA doesn’t collect or record 393 
paternal age in its database, precluding future studies using its database to assess the 394 
impact of paternal age rather than just a select population of sperm donor age on live birth 395 
outcome.  396 
Conclusions: 397 
 Presence of limited and inconclusive medical literature on the effect of paternal age on 398 
success of medically assisted reproduction has precluded a firm ceiling on male or sperm 399 
donor age in relation to paternal reproductive potential. The study suggests that there is a 400 
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lack of evidence for any adverse effect of advancing sperm donor age up to 45 on live birth 401 
and miscarriage occurrence, which arguably are the most important measures of success of 402 
MAR. We postulate that, perhaps, moderation is required as regards the conservative 403 
limitation of the upper limit of age for semen donors, although this would require further 404 
studies to decide on an appropriate cut-off. In addition, we hope this study would provide 405 
reassurance to women limited by choice of available sperm donors regarding the impact of 406 
age of sperm donor on achieving a live birth. 407 
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Figure Legends: 525 
Figure 1: Flow chart depicting the number of cases at each stage of selection. 526 
Exclusions in dashed line boxes. 527 
Inclusions in solid line boxes. 528 
Figure 2: Odds of having a live birth occurrence in different sperm donor age categories in DI 529 
treatment cycles 530 
Figure 3: Odds of having a live birth occurrence in different sperm donor age categories in 531 
IVF/ICSI treatment group. 532 
Supplementary data- Figure 1: Flow chart depicting the number of cases included in 533 
miscarriage analysis. 534 
Exclusions in dashed line boxes. 535 
Inclusions in solid line boxes. 536 
 537 
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Figure 1: Flow chart depicting the number of cases at each stage of selection. 
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 Table 1: Odds ratio for live birth occurrence among all the donor age categories 
in DI treatment group 
 
SPERM 
DONOR AGE  
CATEGORIES 
       LIVE BIRTH IN DI TREATMENT GROUP 
18-34 YEARS OLD WOMEN 35-37 YEARS OLD WOMEN 38-50 YEARS OLD WOMEN 
ODDS RATIO  
(95% CI) 
p-value   ODDS RATIO 
(95% CI) 
p-value   ODDS RATIO 
(95% CI) 
p-value   
≤ 20 years 0.78  (0.64-0.95) 0.015 1.20 (0.78-1.85) 0.397 0.67 (0.36-1.24) 0.202 
21-25 years 0.86  (0.73-1.02) 0.079 0.95 (0.66-1.35) 0.765 0.97 (0.63-1.48)  0.882 
26-30 years 0.98  (0.82-1.16) 0.795 1.14 (0.79-1.65) 0.472 1.08 (0.68-1.67) 0.736 
31-35 years 0.91  (0.76-1.10) 0.321 1.26 (0.86-1.84) 0.234 1.02 (0.64-1.61) 0.940 
36-40 years 0.98  (0.81-1.19) 0.866 1.08 (0.72-1.61) 0.713 1.14 (0.71-1.82) 0.589 
41-45 years 1  1  1  
 
 
 
Table 2: Odds ratio for live birth occurrence among all the donor age categories 
in IVF/ICSI treatment groups 
SPERM 
DONOR AGE  
CATEGORIES 
                                LIVE BIRTH IN IVF/ICSI TREATMENT GROUP 
18-34 YEARS OLD WOMEN 35-37 YEARS OLD WOMEN 38-50 YEARS OLD WOMEN 
ODDS RATIO   
(95% CI) 
p-value   ODDS RATIO    
(95% CI) 
p-value   ODDS RATIO   
(95% CI) 
p-value   
≤ 20 years 0.85  (0.61-1.19) 0.340 0.84 (0.46-1.52) 0.564 0.64 (0.34-1.22) 0.179 
21-25 years 0.76  (0.59-0.99) 0.042 0.68 (0.43-1.06) 0.089 0.76 (0.49-1.18) 0.227 
26-30 years 0.87  (0.66-1.14) 0.306 0.74 (0.47-1.18) 0.210 1.06 (0.68-1.65) 0.797 
31-35 years 0.79  (0.59-1.06) 0.110 0.59 (0.35-0.98) 0.044 0.89 (0.55-1.45) 0.639 
36-40 years 0.92  (0.69-1.24) 0.598 1.035 (0.64-1.69) 0.889 0.86 (0.53-1.39) 0.532 
41-45 years 1  1  1  
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Table 3: Odds ratio for miscarriage occurrence among all the donor age 
categories in DI treatment group 
 
SPERM 
DONOR AGE  
CATEGORIES 
      MISCARRIAGE IN DI TREATMENT GROUP 
18-34 YEARS OLD WOMEN 35-37 YEARS OLD WOMEN 38-50 YEARS OLD WOMEN 
ODDS RATIO  
(95% CI) 
p-value   ODDS RATIO 
(95% CI) 
p-value   ODDS RATIO 
(95% CI) 
p-value   
≤20 years 1.15  (0.62-2.12) 0.665 1.86 (0.78-4.42) 0.161 0.92 (0.45-1.89) 0.813 
21-25 years 1.36  (0.79-2.33) 0.267 1.11  (0.51-2.41) 0.789 0.60  (0.34-1.08) 0.089 
26-30 years 1.24  (0.71-2.17) 0.453 1.24 (0.56-2.75) 0.592 0.56 (0.30-1.04) 0.066 
31-35 years 1.48  (0.84-2.62) 0.180 1.14 (0.49-2.64) 0.761 0.65 (0.34-1.23) 0.185 
36-40 years 1.49  (0.82-2.72) 0.187 1.43 (0.62-3.30) 0.409 0.62 (0.31-1.23) 0.170 
41-45 years 1  1  1  
 
 
 
Table 4: Odds ratio for miscarriage occurrence among all the donor age 
categories in IVF/ICSI treatment groups including embryos transferred per cycle 
as covariate.  
 
 
 
SPERM 
DONOR AGE  
CATEGORIES 
               MISCARRIAGE IN IVF/ICSI TREATMENT GROUP 
18-34 YEARS OLD WOMEN 35-37 YEARS OLD WOMEN 38-50 YEARS OLD WOMEN 
ODDS RATIO  
(95% CI) 
p-value   ODDS RATIO 
(95% CI) 
p-value   ODDS RATIO 
(95% CI) 
p-value   
≤ 20 years 2.46 (0.77-7.82) 0.128 0.93 (0.29-2.94) 0.902 0.63 (0.22-1.77) 0.379 
21-25 years 3.14  (1.20-8.23) 0.020 0.70 (0.30-1.64) 0.416 0.63 (0.32-1.25) 0.187 
26-30 years 2.31  (0.86-6.22) 0.099 0.42 (0.17-1.06) 0.066 0.48 (0.23-1.02) 0.055 
31-35 years 1.55  (0.52-4.59) 0.433 0.67 (0.27-1.65) 0.384 0.55 (0.25-1.17) 0.121 
36-40 years 3.37  (1.26-9.02) 0.016 0.61 (0.25-1.46) 0.268 0.81 (0.41-1.61) 0.554 
41-45 years 1  1  1  
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Supplementary data-Figure 1: Flow chart depicting the number of cases included in miscarriage analysis. 
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  Table 1: Numbers of women in different donor age categories.   
 
 
 
Donor age                                      DI TREATMENT GROUP                                IVF/ICSI TREATMENT GROUP 
 18-34 WOMEN 35-37 WOMEN 38-50 WOMEN 18-34 WOMEN 35-37 WOMEN 38-50 WOMEN 
≤ 20 YEARS 2823 548 505 309 102 153 
21-25 YEARS 9012 2106 1879 1106 393 613 
26-30 YEARS 5880 1459 1457 832 322 467 
31-35 YEARS 3990 1064 1096 544 204 321 
35-40 YEARS 2705 849 910 483 200 332 
41-45 YEARS 1515 533 643 350 138 235 
TOTAL 25925 6559 6490 3624 1359 2121 
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Table 2: Mean number of embryos transferred per cycle in IVF/ICSI treatment group. Dunnett t (>control) 
 
SPERM DONOR 
AGE  CATEGORIES 
(I) 
18-34 YEARS WOMEN SUB-GROUP 
 
35-37 YEARS WOMEN SUB-GROUP 
 
38-50 YEARS WOMEN SUB-GROUP 
 
Mean 
embryo 
transferred 
per cycle 
Difference of 
Means when 
compared to 
Reference  category  
 (95% CI- lower 
bound) 
p-
value 
Mean 
embryo 
transferred 
per cycle 
Difference of Means 
when compared to 
Reference  category   
 (95% CI-lower 
bound) 
p-
value 
Mean 
embryo 
transferred 
per cycle 
Difference of Means 
when compared to 
Reference  category   
 (95% CI-lower 
bound) 
 
p-value   
<= 20 YEARS 2.05 0.49  (0.34) 0.000                   2.14 0.49  (0.23)  0.000 1.99 0.34  (0.12) 0.001  
21-25 YEARS 1.99 0.44  (0.32) 0.000             2.04 0.39  (0.20) 0.000 1.89 0.24  (0.07) 0.003  
26-30 YEARS 1.94 0.39  (0.27) 0.000                   1.89 0.24  (0.04) 0.016 1.86 0.22  (0.05) 0.010  
31-35 YEARS 1.71 0.16  (0.03) 0.017             1.80 0.15  (-0.06) 0.175 1.81 0.17  (-0.01) 0.071  
36-40 YEARS 1.66 0.10  (-0.03) 0.146                    1.64 -0.005 (-0.22) 0.812 1.66 0.02  (-0.17) 0.732  
41-45 YEARS 1.55   1.65   1.64   
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 Table 3: Mean number of embryos created per cycle in IVF/ICSI treatment group. One way ANOVA was used to compare 
means. 
 
 
SPERM DONOR 
AGE  CATEGORIES  
18-34 YEARS WOMEN SUB-GROUP 
 
35-37 YEARS WOMEN SUB-GROUP 
 
38-50 YEARS WOMEN SUB-GROUP 
 
Mean embryo created per 
cycle 
One way 
ANOVA 
p-value 
Mean embryo created per cycle One way 
ANOVA 
p-value 
Mean embryo created per cycle One way 
ANOVA 
p-value   
<= 20 YEARS 6.51  
 
0.895 
5.23  
 
0.561 
4.73  
 
0.534 
21-25 YEARS 6.31 5.14 4.42 
26-30 YEARS 6.21 4.88 4.57 
31-35 YEARS 6.30 5.34 4.82 
36-40 YEARS 6.42 5.59 4.28 
41-45 YEARS 6.53 5.31 4.38 
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 Table 4:  Odds ratio for live birth occurrence among all the donor age categories in IVF/ICSI treatment groups with number     
of embryos transferred as covariate. 
 
 
SPERM 
DONOR AGE  
CATEGORIES 
  LIVE BIRTH IN IVF/ICSI TREATMENT GROUP WITH NUMBER OF EMBRYOS TRANSFERRED 
AS COVARIATE  
18-34 YEARS OLD WOMEN 35-37 YEARS OLD WOMEN 38-50 YEARS OLD WOMEN 
ODDS RATIO  
(95% CI) 
p-value   ODDS RATIO    
(95% CI) 
p-value   ODDS RATIO   
(95% CI) 
p-value   
≤ 20 years 0.64  (0.45-0.90) 0.010 0.62 (0.34-1.14) 0.125 0.52 (0.27-0.99) 0.048 
21-25 years 0.59  (0.45-0.77) 0.000 0.52 (0.33-0.84) 0.007 0.65 (0.41-1.01) 0.058 
26-30 years 0.70  (0.53-0.92) 0.010 0.63 (0.39-1.01) 0.057 0.92 (0.59-1.45) 0.722 
31-35 years 0.71  (0.52-0.95) 0.022 0.52 (0.31-0.89) 0.017 0.80 (0.50-1.32) 0.385 
36-40 years 0.86  (0.64-1.17) 0.342 1.04 (0.64-1.71) 0.870 0.84 (0.51-1.37) 0.473 
41-45 years 1  1  1  
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